A single publication utilizing the E2 metabolite 2-methoxyestradiol (2-ME), which binds poorly to the nuclear ER, showed increased expression of SPON1 in endometrial cancer cell lines [89]. This evidence concerns the gene SPON1 and endometrial cancer.